April 11 (Reuters) - Orchid Pharma Ltd ORCD.NS :
* Got establishment inspection report from USFDA based on successful inspection
closure for the API manufacturing facility at Alathur
* Source text:
Orchid Pharma Ltd has informed BSE that Orchid received the Establishment inspection report (EIR) from USFDA based on the successful inspection closure for the API manufacturing facility located at Alathur, Kancheepuram District, India. The facility was inspected by USFDA in the month of August 2015.
* Further company coverage ORCD.NS
((Bengaluru Newsroom; +91 80 6749 1130))